Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

3D-Quantitated lung perfusion 99mTc-MAA SPECT/CT: Impact on intended management in comparison to planar (2D) lung perfusion scan in lung cancer patients

Alin Chirindel, Michal Cachovan, Alexander Hans Vija, Makhmudbek Mallaev, Daiana Stolz, Michael Tamm, Didier Lardinois, Damian Wild and Guillaume Nicolas
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 299;
Alin Chirindel
2Nuclear Medicine Dpt, University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michal Cachovan
3Siemens Healthcare GmbH Forchheim Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Hans Vija
4Siemens Medical Solutions USA, Inc. Hoffman Estates IL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Makhmudbek Mallaev
7Division of Thorax Surgery University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daiana Stolz
6Division of Pneumology and Lung Cancer Centre University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Tamm
1Division of Pneumology and Lung Cancer Centre, Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Didier Lardinois
7Division of Thorax Surgery University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damian Wild
5University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Nicolas
2Nuclear Medicine Dpt, University Hospital Basel Basel Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

299

Objectives: Prior to lung resection, predicting the postoperative lung function is of paramount importance. The current practice uses planar (2D) scintigraphy. We have previously shown that 3D quantitated SPECT is more accurate than 2D in determining lobar perfusion. We aim to assess the impact of 3D-quantitated lung perfusion SPECT/CT on the operability of lung cancer patients.

Methods: Post-hoc, single centre study in consecutive patients with suspected or known lung cancer, undergoing pre-operative evaluation with lung perfusion imaging and pulmonary function tests (PFT). 99mTc-MAA planar and SPECT/CT lung perfusion scans were performed on a single imaging system (Intevo, Siemens). The lobar contribution to the total lung perfusion was assessed using the established 2D-projection method and the 3D-anatomical method (CT Pulmo 3D and xSPECT-Quant - Siemens). The accuracy of the two evaluation methods was tested against a computational anthropomorphic chest phantom (XCAT). Predictive post-operative PFT (PPO PFT) was calculated according to the established formula: PPO PFT =pre-operative PFT[asterisk](1-fraction of lung perfusion to be resected). According to current guidelines, patients were deemed operable with a PPO PFT >40% of the predicted.

Results: From 10/2016 to 10/2017, we enrolled 50 patients (20 females) with the following baseline demographics (mean±Std deviation): age 69.2y±8.2, FEV1 (forced expiratory volume in one second) 69.9%±21.5, DLCO (diffusing capacity of the lung for CO) 58.0%±19.3, VO2max (maximum rate of oxygen consumption during exercise) (% of the normal predicted value). There were significant differences between the lobar perfusion when comparing the percentage lobar perfusion with the two methods, with 22/50 patients (44%) having >10% difference in at least one lobe. 3D-method was highly accurate in estimating the lobar contribution of the XCAT phantom compared to the standard 2D, with a mean absolute bias of 0.4% and 9.6%, respectively. When integrated into the clinical decision, SPECT/CT-based (3D) evaluation of the lung perfusion would have modified the intended surgical management in 7/50 patients (14%) - from operable to non-operable (n=4) or from non-operable to operable (n=3).

Conclusions: 3D Quantification of lung perfusion is significantly different and substantially more accurate than the currently used 2D-method. Evaluation of oncological patient cohort demonstrates a change in the intended surgical management in 14% of patients when this 3D method is integrated in the clinical decision algorithm.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
3D-Quantitated lung perfusion 99mTc-MAA SPECT/CT: Impact on intended management in comparison to planar (2D) lung perfusion scan in lung cancer patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
3D-Quantitated lung perfusion 99mTc-MAA SPECT/CT: Impact on intended management in comparison to planar (2D) lung perfusion scan in lung cancer patients
Alin Chirindel, Michal Cachovan, Alexander Hans Vija, Makhmudbek Mallaev, Daiana Stolz, Michael Tamm, Didier Lardinois, Damian Wild, Guillaume Nicolas
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 299;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
3D-Quantitated lung perfusion 99mTc-MAA SPECT/CT: Impact on intended management in comparison to planar (2D) lung perfusion scan in lung cancer patients
Alin Chirindel, Michal Cachovan, Alexander Hans Vija, Makhmudbek Mallaev, Daiana Stolz, Michael Tamm, Didier Lardinois, Damian Wild, Guillaume Nicolas
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 299;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • The Metabolic Superscan
  • FDG-PET/CT in the assessment of rheumatoid arthritis disease activity, complications, and treatment response
  • Evolution of the Gold Standard: Gastric Emptying scintigraphy beyond total gastric emptying.
Show more General Clinical Specialties

Outcomes/Infectious Disease/Pulmonary II

  • Collagen-Targeted PET Imaging in Pulmonary Fibrosis: Initial Human Experience
  • CT guided Technetium-99m Macroaggregated albumin injection for lung nodule localization prior to video-assisted thoracoscopic surgery: A single institutional experience
Show more Outcomes/Infectious Disease/Pulmonary II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire